Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis

INTRODUCTION: The addition of immune checkpoint inhibitors (ICIs) to conventional chemotherapy (CT) as first-line treatment improves survival in extensive-stage small-cell lung cancer (ES-SCLC). The aim of this meta-analysis was to determine the relative efficacy of first-line ICIs compared with CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Arriola, Edurne, González-Cao, María, Domine, Manuel, De Castro, Javier, Cobo, Manuel, Bernabé, Reyes, Navarro, Alejandro, Sullivan, Ivana, Trigo, José Manuel, Mosquera, Joaquín, Crama, Leonardo, Isla, Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098752/
https://www.ncbi.nlm.nih.gov/pubmed/35032007
http://dx.doi.org/10.1007/s40487-021-00182-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098752/
https://www.ncbi.nlm.nih.gov/pubmed/35032007
http://dx.doi.org/10.1007/s40487-021-00182-0

Ejemplares similares